Research and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
New test could predict arthritis drug failure in patients
A study by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them.
“We’ve reduced treatment-related deaths among Indian children with leukaemia”
The research team is testing a new approach to treating childhood ALL in India by identifying patients who do not require intensive therapy, thereby decreasing both the cost and burden of treatment.
Children’s research at the NIHR / Wellcome Trust Manchester Clinical Research Facility boosted through new partnership with PPD
Through the network, CMFT aims to attract additional paediatric studies and provide participation in research as a treatment option for more children with rare diseases.
Cheadle Hulme School students add their voice to key NHS research in Manchester
Sixth Form students at Cheadle Hulme School are contributing to vital research in experimental medicine as part of a new public and patient involvement and engagement group at the CMFT
The Experimental Weekender
Fantastic forces, superhuman strength, awesome acrobats, magic materials and groovy graphene are just some of the things you'll see at The Experimental Weekender.
Researchers identify gene mutation that can cause key-hole shape defect in eye
A scientific collaboration has pinpointed the genetic cause of a rare form of blindness, which can present itself as a key-hole shaped defect in the eye in newborn babies.
Researchers recruit first UK patient to pain relief study
Researchers have recruited the first participant onto a research study comparing the effectiveness of pain relief medicine tapentadol to morphine in children and young people.
Royal Manchester Children’s Hospital patient first-in-the-world to take part in pioneering trial to help patients with rare genetic condition
First child in the world to participate in a new trial which could alter the lives of those with Niemann-Pick Disease type B (NPD), a rare inherited metabolic disorder.